UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Progression-specific genes identified in microdissected formalin-fixed and paraffin-embedded tissue containing matched ductal carcinoma in situ and invasive ductal breast cancers

BMC medical genomics, 2018-09, Vol.11 (1), p.80-12, Article 80

2018

Volltextzugriff (PDF)

Antitumor activity of zoledronic acid in primary breast cancer cells determined by the ATP tumor chemosensitivity assay

BMC cancer, 2012-07, Vol.12 (1), p.308-308, Article 308

2012

Volltextzugriff (PDF)

Prediction of breast cancer by profiling of urinary RNA metabolites using Support Vector Machine-based feature selection

BMC cancer, 2009-04, Vol.9 (104), p.104-104, Article 104

2009

Volltextzugriff (PDF)

The effect of progesterone, testosterone and synthetic progestogens on growth factor- and estradiol-treated human cancerous and benign breast cells

European journal of obstetrics & gynecology and reproductive biology, 2006-11, Vol.129 (1), p.77-83

2006

Volltextzugriff (PDF)

The presence of a membrane-bound progesterone receptor induces growth of breast cancer with norethisterone but not with progesterone: A xenograft model

Maturitas, 2017-08, Vol.102, p.26-33

2017

Volltextzugriff (PDF)

Efficacy of neoadjuvant pertuzumab in addition to chemotherapy and trastuzumab in routine clinical treatment of patients with primary breast cancer: a multicentric analysis

Breast cancer research and treatment, 2019-01, Vol.173 (2), p.319-328

2019

Volltextzugriff (PDF)

Metabolomics approach for predicting response to neoadjuvant chemotherapy for breast cancer

Molecular oncology, 2013-06, Vol.7 (3), p.297-307

2013

Volltextzugriff (PDF)

Progesterone receptor membrane component 1 is phosphorylated upon progestin treatment in breast cancer cells

Oncotarget, 2017-09, Vol.8 (42), p.72480-72493

2017

Volltextzugriff (PDF)

May progesterone receptor membrane component 1 (PGRMC1) predict the risk of breast cancer?

Gynecological endocrinology, 2016-01, Vol.32 (1), p.58-60

2016

Volltextzugriff (PDF)

Pregnancy-associated breast cancer: maternal breast cancer survival over 10 years and obstetrical outcome at a university centre of women’s health

Archives of gynecology and obstetrics, 2018-08, Vol.298 (2), p.363-372

2018

Volltextzugriff (PDF)

The ratio of the estradiol metabolites 2-hydroxyestrone (2-OHE1) and 16α-hydroxyestrone (16-OHE1) may predict breast cancer risk in postmenopausal but not in premenopausal women: two case–control studies

Archives of gynecology and obstetrics, 2015-05, Vol.291 (5), p.1141-1146

2015

Volltextzugriff (PDF)

Ultrasound-Assisted Tumor Surgery in Breast Cancer - A Prospective, Randomized, Single-Center Study (MAC 001)

Ultraschall in der Medizin, 2019-06, Vol.40 (3), p.326-332

2019

Volltextzugriff (PDF)

Oestetrol stimulates proliferation and oestrogen receptor expression in breast cancer cell lines: Comparison of four oestrogens

The European journal of contraception & reproductive health care, 2015-02, Vol.20 (1), p.29-35

2015

Volltextzugriff (PDF)

ADAM12 expression predicts clinical outcome in estrogen receptor-positive breast cancer

International journal of clinical and experimental pathology, 2015-01, Vol.8 (10), p.13279-13283

2015

Volltextzugriff (PDF)

Cytotoxicity of the new antimetabolite-bisphosphonate (5-FdU-alendronate) in comparison to standard therapeutics on breast and ovarian cancer cell lines in the ATP tumor chemosensitivity assay

Investigational new drugs, 2012-08, Vol.30 (4), p.1750-1755

2012

Volltextzugriff (PDF)

Breast cancer: Are oestrogen metabolites carcinogenic?

Maturitas, 2007-05, Vol.57 (1), p.42-46

2007

Volltextzugriff (PDF)

ATP chemosensitivity testing of new antitumor duplex drugs linking 3`-C-ethynylycytidine (ECyd) and 2´-deoxy-5-fluorouridine (5-FdU) in comparison to standard cytostatica and combinations thereof

Investigational new drugs, 2011-06, Vol.29 (3), p.506-513

2011

Volltextzugriff (PDF)

Risk of breast cancer during hormone replacement therapy: mechanisms

Hormone molecular biology and clinical investigation, 2010-12, Vol.3 (1), p.329-339

2010

Volltextzugriff (PDF)

Use of dydrogesterone in hormone replacement therapy

Maturitas, 2009-12, Vol.65, p.S51-S60

2009

Volltextzugriff (PDF)

Risk of breast cancer during hormone replacement therapy: mechanisms

Hormone molecular biology and clinical investigation, 2010-12, Vol.3 (1), p.329-339

2010

Volltextzugriff (PDF)

Comparison of the effect of progesterone, medroxyprogesterone acetate and norethisterone on the proliferation of human breast cancer cells

The journal of the British Menopause Society, 2003-03, Vol.9 (1), p.36-38

2003

Volltextzugriff (PDF)

1 – 21 von 21

Suche als RSS-Feed

Aktive Filter

Zeitschrift / SerieMenopause

ThemaBreast Cancer

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(18)
Mit Volltextzugriff
(17)

Publikationsform

Artikel
(21)

Sprache

Englisch
(21)

Erscheinungsjahr

n.n

Thema

14 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Progression-specific genes identified in microdissected formalin-fixed and paraffin-embedded tissue containing matched ductal carcinoma in situ and invasive ductal breast cancers

Antitumor activity of zoledronic acid in primary breast cancer cells determined by the ATP tumor chemosensitivity assay

Prediction of breast cancer by profiling of urinary RNA metabolites using Support Vector Machine-based feature selection

The effect of progesterone, testosterone and synthetic progestogens on growth factor- and estradiol-treated human cancerous and benign breast cells

The presence of a membrane-bound progesterone receptor induces growth of breast cancer with norethisterone but not with progesterone: A xenograft model

Efficacy of neoadjuvant pertuzumab in addition to chemotherapy and trastuzumab in routine clinical treatment of patients with primary breast cancer: a multicentric analysis

Metabolomics approach for predicting response to neoadjuvant chemotherapy for breast cancer

Progesterone receptor membrane component 1 is phosphorylated upon progestin treatment in breast cancer cells

May progesterone receptor membrane component 1 (PGRMC1) predict the risk of breast cancer?

Pregnancy-associated breast cancer: maternal breast cancer survival over 10 years and obstetrical outcome at a university centre of women’s health

The ratio of the estradiol metabolites 2-hydroxyestrone (2-OHE1) and 16α-hydroxyestrone (16-OHE1) may predict breast cancer risk in postmenopausal but not in premenopausal women: two case–control studies

Ultrasound-Assisted Tumor Surgery in Breast Cancer - A Prospective, Randomized, Single-Center Study (MAC 001)

Oestetrol stimulates proliferation and oestrogen receptor expression in breast cancer cell lines: Comparison of four oestrogens

ADAM12 expression predicts clinical outcome in estrogen receptor-positive breast cancer

Cytotoxicity of the new antimetabolite-bisphosphonate (5-FdU-alendronate) in comparison to standard therapeutics on breast and ovarian cancer cell lines in the ATP tumor chemosensitivity assay

Breast cancer: Are oestrogen metabolites carcinogenic?

ATP chemosensitivity testing of new antitumor duplex drugs linking 3`-C-ethynylycytidine (ECyd) and 2´-deoxy-5-fluorouridine (5-FdU) in comparison to standard cytostatica and combinations thereof

Risk of breast cancer during hormone replacement therapy: mechanisms

Use of dydrogesterone in hormone replacement therapy

Risk of breast cancer during hormone replacement therapy: mechanisms

Comparison of the effect of progesterone, medroxyprogesterone acetate and norethisterone on the proliferation of human breast cancer cells

Aktive Filter

Suchergebnisse filtern